Answers are grounded in this paper and cite their sources.
Urinary fibrin/fibrinogen degradation products as biological tumor markers in urothelial carcinoma have been studied and compared to urinary cytology. In 93 per cent of the patients with urothelial carcinoma urinary fibrin/fibrinogen degradation product levels were elevated significantly. There was excellent correlation when the urinary cytology and urinary fibrin/fibrinogen degradation product results were compared together to cystoscopic findings.
No takes yet. Share an insight, caveat, or question.
Mooppan et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: